From disease onset to therapeutic response, Immunology and Inflammation research increasingly relies on biomarker data that must be robust, translatable, and biologically meaningful. Clinicians and translational teams now require the simultaneous assessment of growing numbers of biomarkers to better capture disease complexity, patient heterogeneity, and treatment response.
To expedite your research and minimize development costs, we have translated our years of immunology and inflammatory biomarker expertise into 23 ready-to-use panels. These panels are designed to address key disease-relevant questions about disease onset, progression, and response to therapy, including for example:
- Immune cell activation and differentiation
- Cytokine and chemokine signaling
- Tissue inflammation
- Pathway dysregulation
- Patient stratification
Download the brochure to view a full list of panels and biomarkers in our Immunology & Inflammation Collection.
